Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - DiaMedica Therapeutics Inc.ex_178141.htm
EX-32.1 - EXHIBIT 32.1 - DiaMedica Therapeutics Inc.ex_178140.htm
EX-31.2 - EXHIBIT 31.2 - DiaMedica Therapeutics Inc.ex_178139.htm
EX-31.1 - EXHIBIT 31.1 - DiaMedica Therapeutics Inc.ex_178138.htm
EX-21.1 - EXHIBIT 21.1 - DiaMedica Therapeutics Inc.ex_178136.htm
EX-10.19 - EXHIBIT 10.19 - DiaMedica Therapeutics Inc.ex_178135.htm
EX-4.8 - EXHIBIT 4.8 - DiaMedica Therapeutics Inc.ex_178134.htm
EX-4.1 - EXHIBIT 4.1 - DiaMedica Therapeutics Inc.ex_178133.htm
10-K - FORM 10-K - DiaMedica Therapeutics Inc.dmtp20191231_10k.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-235775) and Form S-8 (File Nos. 333-228821 and 333-231717) of DiaMedica Therapeutics Inc. of our report dated March 23, 2020, relating to the consolidated financial statements of DiaMedica Therapeutics Inc., which appears in this annual report on Form 10-K for the fiscal year ended December 31, 2019.

 

 

/s/ BAKER TILLY VIRCHOW KRAUSE, LLP

 

Minneapolis, Minnesota

March 23, 2020